The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-06-02

AUTHORS

Harsh Mathur, Mary C. Rea, Paul D. Cotter, Colin Hill, R. Paul Ross

ABSTRACT

BackgroundThuricin CD is a two-component antimicrobial, belonging to the recently designated sactibiotic subclass of bacteriocins. The aim of this study was to investigate the effects of thuricin CD, as well as the antibiotics, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide when used independently and when combined at low concentrations on the viability of Clostridium difficile 20291 R027, TL178 R002, Liv022 R106, DPC6350 and VPI10463 biofilms and planktonic cells.ResultsOn the basis of XTT (2,3-bis[2-methyloxy-4-nitro-5-sulphophenyl]-2H-tetrazolium-5-carboxanilide)-menadione biofilm viability assays, we found that thuricin CD was effective against biofilms of R027, Liv022 R106 and DPC6350 when used independently while nitazoxanide and rifampicin were also potent against biofilms of R027 and DPC6350, when applied on their own. Tigecycline was found to be effective against R027 and DPC6350 biofilms, whereas teicoplanin and vancomycin when used independently were only effective against DPC6350 biofilms. The efficacies of the antibiotics rifampicin, tigecycline, vancomycin and teicoplanin against C. difficile 20291 R027 biofilms were significantly potentiated when combined with thuricin CD, indicating effective antimicrobial combinations with this sactibiotic against R027 biofilms. However, the potency of nitazoxanide against R027 biofilms was significantly diminished when combined with thuricin CD, indicating an ineffective combination with this sactibiotic against R027 biofilms. Paired combinations of thuricin CD along with these five antibiotics were effective at diminishing the viability of DPC6350 biofilms. However, such combinations were largely ineffective against biofilms of TL178 R002, Liv022 R106 and VPI10463.ConclusionsTo the best of our knowledge, this is the first study to highlight the activity of a sactibiotic bacteriocin against biofilms and the first to reveal the potency of the antibiotics tigecycline, teicoplanin and nitazoxanide against C. difficile biofilms. On the basis of this study, it is apparent that different strains of C. difficile possess varying abilities to form biofilms and that the sensitivities of these biofilms to different antimicrobials and antimicrobial combinations are strain-dependent. Since the formation of relatively strong biofilms by certain C. difficile strains may contribute to increased cases of antibiotic resistance and recurrence and relapse of C. difficile infection, the findings presented in this study could provide alternative strategies to target this pathogen. More... »

PAGES

20

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13099-016-0102-8

DOI

http://dx.doi.org/10.1186/s13099-016-0102-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029140563

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27257437


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Teagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.6435.4", 
          "name": [
            "School of Microbiology, University College Cork, Cork, Ireland", 
            "Teagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mathur", 
        "givenName": "Harsh", 
        "id": "sg:person.01131201266.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131201266.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Alimentary Pharmabiotic Centre Microbiome Institute, University College Cork, Cork, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.7872.a", 
          "name": [
            "Teagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland", 
            "Alimentary Pharmabiotic Centre Microbiome Institute, University College Cork, Cork, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rea", 
        "givenName": "Mary C.", 
        "id": "sg:person.0737720307.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737720307.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Alimentary Pharmabiotic Centre Microbiome Institute, University College Cork, Cork, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.7872.a", 
          "name": [
            "Teagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland", 
            "Alimentary Pharmabiotic Centre Microbiome Institute, University College Cork, Cork, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cotter", 
        "givenName": "Paul D.", 
        "id": "sg:person.0622117443.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622117443.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Alimentary Pharmabiotic Centre Microbiome Institute, University College Cork, Cork, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.7872.a", 
          "name": [
            "School of Microbiology, University College Cork, Cork, Ireland", 
            "Alimentary Pharmabiotic Centre Microbiome Institute, University College Cork, Cork, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hill", 
        "givenName": "Colin", 
        "id": "sg:person.01202224511.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202224511.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "College of Science, Engineering and Food Science, University College Cork, Cork, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.7872.a", 
          "name": [
            "Alimentary Pharmabiotic Centre Microbiome Institute, University College Cork, Cork, Ireland", 
            "College of Science, Engineering and Food Science, University College Cork, Cork, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ross", 
        "givenName": "R. Paul", 
        "id": "sg:person.014605670062.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014605670062.43"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature03912", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020404004", 
          "https://doi.org/10.1038/nature03912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-540-75418-3_6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047337753", 
          "https://doi.org/10.1007/978-3-540-75418-3_6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-540-75418-3_10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010961510", 
          "https://doi.org/10.1007/978-3-540-75418-3_10"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-06-02", 
    "datePublishedReg": "2016-06-02", 
    "description": "BackgroundThuricin CD is a two-component antimicrobial, belonging to the recently designated sactibiotic subclass of bacteriocins. The aim of this study was to investigate the effects of thuricin CD, as well as the antibiotics, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide when used independently and when combined at low concentrations on the viability of Clostridium difficile 20291 R027, TL178 R002, Liv022 R106, DPC6350 and VPI10463 biofilms and planktonic cells.ResultsOn the basis of XTT (2,3-bis[2-methyloxy-4-nitro-5-sulphophenyl]-2H-tetrazolium-5-carboxanilide)-menadione biofilm viability assays, we found that thuricin CD was effective against biofilms of R027, Liv022 R106 and DPC6350 when used independently while nitazoxanide and rifampicin were also potent against biofilms of R027 and DPC6350, when applied on their own. Tigecycline was found to be effective against R027 and DPC6350 biofilms, whereas teicoplanin and vancomycin when used independently were only effective against DPC6350 biofilms. The efficacies of the antibiotics rifampicin, tigecycline, vancomycin and teicoplanin against C. difficile 20291 R027 biofilms were significantly potentiated when combined with thuricin CD, indicating effective antimicrobial combinations with this sactibiotic against R027 biofilms. However, the potency of nitazoxanide against R027 biofilms was significantly diminished when combined with thuricin CD, indicating an ineffective combination with this sactibiotic against R027 biofilms. Paired combinations of thuricin CD along with these five antibiotics were effective at diminishing the viability of DPC6350 biofilms. However, such combinations were largely ineffective against biofilms of TL178 R002, Liv022 R106 and VPI10463.ConclusionsTo the best of our knowledge, this is the first study to highlight the activity of a sactibiotic bacteriocin against biofilms and the first to reveal the potency of the antibiotics tigecycline, teicoplanin and nitazoxanide against C. difficile biofilms. On the basis of this study, it is apparent that different strains of C. difficile possess varying abilities to form biofilms and that the sensitivities of these biofilms to different antimicrobials and antimicrobial combinations are strain-dependent. Since the formation of relatively strong biofilms by certain C. difficile strains may contribute to increased cases of antibiotic resistance and recurrence and relapse of C. difficile infection, the findings presented in this study could provide alternative strategies to target this pathogen.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13099-016-0102-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3984108", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1040046", 
        "issn": [
          "1757-4749"
        ], 
        "name": "Gut Pathogens", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "antimicrobial combinations", 
      "effective antimicrobial combinations", 
      "difficile biofilms", 
      "difficile infection", 
      "tigecycline", 
      "nitazoxanide", 
      "difficile strains", 
      "thuricin CD", 
      "vancomycin", 
      "teicoplanin", 
      "rifampicin", 
      "different antimicrobials", 
      "R027", 
      "antibiotic resistance", 
      "antibiotics", 
      "planktonic cells", 
      "ineffective combination", 
      "viability assays", 
      "efficacy", 
      "strong biofilm", 
      "potency", 
      "first study", 
      "antimicrobials", 
      "different strains", 
      "cells", 
      "relapse", 
      "antibiotic rifampicin", 
      "recurrence", 
      "infection", 
      "study", 
      "low concentrations", 
      "ResultsOn", 
      "such combinations", 
      "alternative strategy", 
      "viability", 
      "bacteriocin", 
      "XTT", 
      "assays", 
      "combination", 
      "aim", 
      "biofilms", 
      "strains", 
      "pathogens", 
      "findings", 
      "menadione", 
      "activity", 
      "cases", 
      "sensitivity", 
      "subclasses", 
      "effect", 
      "resistance", 
      "concentration", 
      "ability", 
      "basis", 
      "strategies", 
      "knowledge", 
      "Cd", 
      "sactibiotics", 
      "possess", 
      "R106", 
      "formation"
    ], 
    "name": "The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells", 
    "pagination": "20", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029140563"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13099-016-0102-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27257437"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13099-016-0102-8", 
      "https://app.dimensions.ai/details/publication/pub.1029140563"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_695.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13099-016-0102-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13099-016-0102-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13099-016-0102-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13099-016-0102-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13099-016-0102-8'


 

This table displays all metadata directly associated to this object as RDF triples.

172 TRIPLES      22 PREDICATES      90 URIs      79 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13099-016-0102-8 schema:about anzsrc-for:11
2 anzsrc-for:1108
3 schema:author N514a21da2c36420fbb4b534dbdf4f657
4 schema:citation sg:pub.10.1007/978-3-540-75418-3_10
5 sg:pub.10.1007/978-3-540-75418-3_6
6 sg:pub.10.1038/nature03912
7 schema:datePublished 2016-06-02
8 schema:datePublishedReg 2016-06-02
9 schema:description BackgroundThuricin CD is a two-component antimicrobial, belonging to the recently designated sactibiotic subclass of bacteriocins. The aim of this study was to investigate the effects of thuricin CD, as well as the antibiotics, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide when used independently and when combined at low concentrations on the viability of Clostridium difficile 20291 R027, TL178 R002, Liv022 R106, DPC6350 and VPI10463 biofilms and planktonic cells.ResultsOn the basis of XTT (2,3-bis[2-methyloxy-4-nitro-5-sulphophenyl]-2H-tetrazolium-5-carboxanilide)-menadione biofilm viability assays, we found that thuricin CD was effective against biofilms of R027, Liv022 R106 and DPC6350 when used independently while nitazoxanide and rifampicin were also potent against biofilms of R027 and DPC6350, when applied on their own. Tigecycline was found to be effective against R027 and DPC6350 biofilms, whereas teicoplanin and vancomycin when used independently were only effective against DPC6350 biofilms. The efficacies of the antibiotics rifampicin, tigecycline, vancomycin and teicoplanin against C. difficile 20291 R027 biofilms were significantly potentiated when combined with thuricin CD, indicating effective antimicrobial combinations with this sactibiotic against R027 biofilms. However, the potency of nitazoxanide against R027 biofilms was significantly diminished when combined with thuricin CD, indicating an ineffective combination with this sactibiotic against R027 biofilms. Paired combinations of thuricin CD along with these five antibiotics were effective at diminishing the viability of DPC6350 biofilms. However, such combinations were largely ineffective against biofilms of TL178 R002, Liv022 R106 and VPI10463.ConclusionsTo the best of our knowledge, this is the first study to highlight the activity of a sactibiotic bacteriocin against biofilms and the first to reveal the potency of the antibiotics tigecycline, teicoplanin and nitazoxanide against C. difficile biofilms. On the basis of this study, it is apparent that different strains of C. difficile possess varying abilities to form biofilms and that the sensitivities of these biofilms to different antimicrobials and antimicrobial combinations are strain-dependent. Since the formation of relatively strong biofilms by certain C. difficile strains may contribute to increased cases of antibiotic resistance and recurrence and relapse of C. difficile infection, the findings presented in this study could provide alternative strategies to target this pathogen.
10 schema:genre article
11 schema:inLanguage en
12 schema:isAccessibleForFree true
13 schema:isPartOf N8ff67f872f94477a8f0b0d421eab364c
14 Nbbde335678c4476bb1874de5601f7e6c
15 sg:journal.1040046
16 schema:keywords Cd
17 R027
18 R106
19 ResultsOn
20 XTT
21 ability
22 activity
23 aim
24 alternative strategy
25 antibiotic resistance
26 antibiotic rifampicin
27 antibiotics
28 antimicrobial combinations
29 antimicrobials
30 assays
31 bacteriocin
32 basis
33 biofilms
34 cases
35 cells
36 combination
37 concentration
38 different antimicrobials
39 different strains
40 difficile biofilms
41 difficile infection
42 difficile strains
43 effect
44 effective antimicrobial combinations
45 efficacy
46 findings
47 first study
48 formation
49 ineffective combination
50 infection
51 knowledge
52 low concentrations
53 menadione
54 nitazoxanide
55 pathogens
56 planktonic cells
57 possess
58 potency
59 recurrence
60 relapse
61 resistance
62 rifampicin
63 sactibiotics
64 sensitivity
65 strains
66 strategies
67 strong biofilm
68 study
69 subclasses
70 such combinations
71 teicoplanin
72 thuricin CD
73 tigecycline
74 vancomycin
75 viability
76 viability assays
77 schema:name The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells
78 schema:pagination 20
79 schema:productId N408bd113d3a54fdaa2d6d0402a54e18e
80 N450628d5daea4e3386932baa70ef83d7
81 N92bd7c0377524fb7b83be750211ad001
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029140563
83 https://doi.org/10.1186/s13099-016-0102-8
84 schema:sdDatePublished 2022-05-10T10:16
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher N1d52dd22a9ef4685977526c638903145
87 schema:url https://doi.org/10.1186/s13099-016-0102-8
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N1d52dd22a9ef4685977526c638903145 schema:name Springer Nature - SN SciGraph project
92 rdf:type schema:Organization
93 N408bd113d3a54fdaa2d6d0402a54e18e schema:name dimensions_id
94 schema:value pub.1029140563
95 rdf:type schema:PropertyValue
96 N440e1858d8ac45d6b599ffd06f2bc3f7 rdf:first sg:person.014605670062.43
97 rdf:rest rdf:nil
98 N450628d5daea4e3386932baa70ef83d7 schema:name doi
99 schema:value 10.1186/s13099-016-0102-8
100 rdf:type schema:PropertyValue
101 N514a21da2c36420fbb4b534dbdf4f657 rdf:first sg:person.01131201266.45
102 rdf:rest N84408d2084a04eb792c3ce84cb4e8d37
103 N52455851ae4a43dd8416f0d7b531755a rdf:first sg:person.01202224511.99
104 rdf:rest N440e1858d8ac45d6b599ffd06f2bc3f7
105 N84408d2084a04eb792c3ce84cb4e8d37 rdf:first sg:person.0737720307.11
106 rdf:rest Nbf409633606f4406a84b985a3e0c8861
107 N8ff67f872f94477a8f0b0d421eab364c schema:volumeNumber 8
108 rdf:type schema:PublicationVolume
109 N92bd7c0377524fb7b83be750211ad001 schema:name pubmed_id
110 schema:value 27257437
111 rdf:type schema:PropertyValue
112 Nbbde335678c4476bb1874de5601f7e6c schema:issueNumber 1
113 rdf:type schema:PublicationIssue
114 Nbf409633606f4406a84b985a3e0c8861 rdf:first sg:person.0622117443.36
115 rdf:rest N52455851ae4a43dd8416f0d7b531755a
116 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
117 schema:name Medical and Health Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical Microbiology
121 rdf:type schema:DefinedTerm
122 sg:grant.3984108 http://pending.schema.org/fundedItem sg:pub.10.1186/s13099-016-0102-8
123 rdf:type schema:MonetaryGrant
124 sg:journal.1040046 schema:issn 1757-4749
125 schema:name Gut Pathogens
126 schema:publisher Springer Nature
127 rdf:type schema:Periodical
128 sg:person.01131201266.45 schema:affiliation grid-institutes:grid.6435.4
129 schema:familyName Mathur
130 schema:givenName Harsh
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131201266.45
132 rdf:type schema:Person
133 sg:person.01202224511.99 schema:affiliation grid-institutes:grid.7872.a
134 schema:familyName Hill
135 schema:givenName Colin
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202224511.99
137 rdf:type schema:Person
138 sg:person.014605670062.43 schema:affiliation grid-institutes:grid.7872.a
139 schema:familyName Ross
140 schema:givenName R. Paul
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014605670062.43
142 rdf:type schema:Person
143 sg:person.0622117443.36 schema:affiliation grid-institutes:grid.7872.a
144 schema:familyName Cotter
145 schema:givenName Paul D.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622117443.36
147 rdf:type schema:Person
148 sg:person.0737720307.11 schema:affiliation grid-institutes:grid.7872.a
149 schema:familyName Rea
150 schema:givenName Mary C.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737720307.11
152 rdf:type schema:Person
153 sg:pub.10.1007/978-3-540-75418-3_10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010961510
154 https://doi.org/10.1007/978-3-540-75418-3_10
155 rdf:type schema:CreativeWork
156 sg:pub.10.1007/978-3-540-75418-3_6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047337753
157 https://doi.org/10.1007/978-3-540-75418-3_6
158 rdf:type schema:CreativeWork
159 sg:pub.10.1038/nature03912 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020404004
160 https://doi.org/10.1038/nature03912
161 rdf:type schema:CreativeWork
162 grid-institutes:grid.6435.4 schema:alternateName Teagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland
163 schema:name School of Microbiology, University College Cork, Cork, Ireland
164 Teagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland
165 rdf:type schema:Organization
166 grid-institutes:grid.7872.a schema:alternateName Alimentary Pharmabiotic Centre Microbiome Institute, University College Cork, Cork, Ireland
167 College of Science, Engineering and Food Science, University College Cork, Cork, Ireland
168 schema:name Alimentary Pharmabiotic Centre Microbiome Institute, University College Cork, Cork, Ireland
169 College of Science, Engineering and Food Science, University College Cork, Cork, Ireland
170 School of Microbiology, University College Cork, Cork, Ireland
171 Teagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland
172 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...